Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic.
about
MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological diseaseEvidence that Par-4 participates in the pathogenesis of HIV encephalitisExtracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytesEstrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaineHIV-1 Tat interacts with LIS1 proteinGonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanismHIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial HyperpolarizationMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersSynergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitroHIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells.Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSRepeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and RevSTAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinNeuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsNeurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.Genetic variation and HIV-associated neurologic disease.Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Effects of HIV-1 Tat on enteric neuropathogenesis.Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibilityHIV neurotoxicity: potential therapeutic interventionsHIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND).Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Tat-induced histopathological alterations mediate hippocampus-associated behavioural impairments in rats.Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a,b)Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementiaCreatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Novel mechanisms of central nervous system damage in HIV infection.Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA [corrected].Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropismMolecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.
P2860
Q24318325-3C9982A5-A7AD-48C2-8BB8-E35F26BEB5C3Q24671184-878F475B-FBB2-465B-A0F2-27050CA7E5DDQ24683736-C2EDDF9A-0207-493B-B191-D954F32DCE90Q24796371-FFDCB1CA-0911-4E7F-91C5-99247C0E47A5Q24807276-3A411F0A-520F-4CEA-8B19-70EB07747EABQ24813383-BA4BBD81-459A-4913-8779-CE520E8CB0BFQ27487322-661FB7E2-8DBE-49F1-B5FD-32E252B5031FQ28082139-1DE52DF1-7311-4C97-8CA8-CE80AC510C2BQ28354326-3E6109CC-F06B-4A21-BBE6-9142C2D973E1Q30638542-0A4360ED-001A-43CE-AA9B-D60538861134Q33566813-84503C26-1DCA-4761-90ED-443B15934240Q33580220-3C959C5C-0EB1-4AAB-AA6F-9FDF79D18B56Q33605370-5556135B-5822-496A-B500-5E44716DE18EQ33639362-79B306FC-2491-48F9-ADBB-26653F51D822Q33675464-662AA03E-5777-4DC3-8D37-307C5B05781FQ33785357-8DA03E2B-D963-44B4-A71A-11E80DD784AFQ33785394-CBB33248-B8BD-4CFA-A7FA-F53C83500EE7Q33795961-6608EA3E-8797-4997-AC37-3DA1D5FCEBB1Q33819189-2D239934-54D8-453E-8BCA-A00755F01C87Q34184281-BDD0D995-27B9-419D-8243-26283A2F97C1Q34197724-8C55E772-CD39-438A-887C-25E2A4DBDAF8Q34383417-35A21935-203B-4814-8FA9-90D6B91D5ABAQ34450960-0783B76C-0047-404D-94D6-81211529E1BCQ34540333-932E31EC-0D65-4A9E-9DE7-6253F7C7BE05Q34755001-4AE446E1-FFB3-41F7-BBAD-C0549EBA5937Q34795283-32C15C17-D2C2-4953-9F71-9E4330EBA775Q34903986-27C37896-0A36-4A44-BAC5-C28BC96E3426Q35009483-46F1A384-91A1-45BB-84FB-2DBB871AFACFQ35019404-24C46BA2-55C6-4881-8263-B0E9001F005BQ35097305-2124CBFE-D77C-434D-B7E4-BA5F21DBEFFCQ35131200-CD9D215D-0BC5-413F-A951-02DD249446FBQ35197030-685432C0-35DB-4916-8D5B-D9F7B11DEC39Q35215063-65094DEF-9B4A-4DC1-AAB1-8D295340DB7AQ35557261-E4A0BA05-F3D5-4A16-9D8D-CDF47CE8E975Q35574768-11A558D8-259F-446E-B843-874471925297Q35763921-378CBE1A-AE1D-4A76-AA5E-E701C88D484DQ35871948-97981AB7-3280-4B3E-AC2E-00CA704F1CB1Q35879801-DB6FE4BD-BCA2-4054-B410-7EEE12F13887Q36010129-7B90DDCB-BA90-463F-A40F-C473A400C6F6Q36148402-7CF58A43-6F12-4E66-A93C-2B308D6CB67E
P2860
Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Identification of a human immu ...... euroexcitatory and neurotoxic.
@ast
Identification of a human immu ...... euroexcitatory and neurotoxic.
@en
type
label
Identification of a human immu ...... euroexcitatory and neurotoxic.
@ast
Identification of a human immu ...... euroexcitatory and neurotoxic.
@en
prefLabel
Identification of a human immu ...... euroexcitatory and neurotoxic.
@ast
Identification of a human immu ...... euroexcitatory and neurotoxic.
@en
P2093
P2860
P1433
P1476
Identification of a human immu ...... euroexcitatory and neurotoxic.
@en
P2093
Magnuson DS
P2860
P304
P407
P577
1996-03-01T00:00:00Z